SANNA, MONICA
 Distribuzione geografica
Continente #
EU - Europa 1.027
AS - Asia 151
NA - Nord America 63
SA - Sud America 7
AF - Africa 2
Totale 1.250
Nazione #
IT - Italia 1.004
SG - Singapore 74
US - Stati Uniti d'America 57
CN - Cina 33
VN - Vietnam 25
DE - Germania 8
FR - Francia 8
HK - Hong Kong 6
BR - Brasile 5
ES - Italia 3
MX - Messico 3
AZ - Azerbaigian 2
BD - Bangladesh 2
FI - Finlandia 2
GB - Regno Unito 2
IN - India 2
JP - Giappone 2
AR - Argentina 1
ET - Etiopia 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
MA - Marocco 1
MN - Mongolia 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 1.250
Città #
Genova 485
Genoa 304
Rapallo 134
Vado Ligure 72
Singapore 40
San Jose 20
Council Bluffs 10
Ho Chi Minh City 10
Lauterbourg 8
Hanoi 7
Beijing 6
Hong Kong 5
Bordighera 4
Frankfurt am Main 4
Ashburn 3
Chicago 3
Madrid 3
Baku 2
Leipzig 2
Mexico City 2
New York 2
Santa Clara 2
Tokyo 2
Acapulco de Juárez 1
Addis Ababa 1
Almese 1
Araranguá 1
Arbuckle 1
Baghdad 1
Basingstoke 1
Buenos Aires 1
Bình Phước 1
Can Tho 1
Carapicuíba 1
Contagem 1
Delaware 1
Falkenstein 1
Guarulhos 1
Harrison 1
Helsinki 1
Lahore 1
Lang Son 1
Lappeenranta 1
Los Angeles 1
Lấp Vò 1
Marrakesh 1
Monaca 1
Mumbai 1
Naples 1
Newport 1
Nuremberg 1
Panama City 1
Phú Thọ 1
Pinhais 1
Quảng Ngãi 1
Rome 1
Salto del Guairá 1
San Diego 1
Seoul 1
Tashkent 1
Tocoa 1
Ulan Bator 1
Totale 1.169
Nome #
Analogs, formulations and derivatives of imatinib: A patent review 200
Design, synthesis and biological evaluation of pyrazolo-pyrimidines and related isosteres as inhibitors of protein kinases, potential antineoplastic agents 151
Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer–Drug Microarrays 143
Pyrrolo[2,3-d]pyrimidines as kinase inhibitors 140
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active in a preclinical glioblastoma model. 118
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors 116
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists. 115
Synthesis of heterocyclic compounds to be tested as potentiators or correctors of mutant CFTR in cystic fibrosis 105
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidine as SGK-1 inhibitors. 103
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidines as Fyn inhibitors 102
Totale 1.293
Categoria #
all - tutte 4.369
article - articoli 1.995
book - libri 0
conference - conferenze 1.920
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 6 8 8
2021/2022152 5 9 2 15 4 19 2 34 14 15 13 20
2022/2023167 18 23 3 27 19 24 0 7 21 1 23 1
2023/202474 4 8 0 12 5 8 1 8 3 1 6 18
2024/2025204 0 14 5 17 15 22 19 51 6 9 20 26
2025/2026320 45 2 11 13 76 31 64 13 22 43 0 0
Totale 1.293